News from us and our partners

Tags

Topics

0 results

News
28 April, 2025
Rasmus Holm-Jorgensen appointed CFO at AAVantgarde
News
28 April, 2025
Mainstay Medical announces exclusive coverage of ReActiv8® by Anthem Blue Cross/Blue Shield
News
28 April, 2025
Purespring Therapeutics granted European Medicines Agency (EMA) orphan drug designation for PS-002 for the treatment of patients with primary IgA nephropathy (IgAN)
News
24 April, 2025
CorWave announces successful completion of 6-month chronic in vivo study, paving the way for clinical trial initiation
Feature
22 April, 2025
2024 Impact Report: Delivering Impact
News
15 April, 2025
iOmx Therapeutics Receives Regulatory Approval of Clinical Trial Application for IOMX-0675
News
14 April, 2025
ProQR strengthens leadership with appointments of CFO and CMO to support next phase of growth
News
8 April, 2025
Myricx Bio Announces Expansion of its Leadership Team to Advance NMTi-ADCs into Clinical Development
News
7 April, 2025
Invivo Partners joins Sofinnova in Signadori Bio
News
7 April, 2025
HighLife granted US FDA Breakthrough Device Designation for its TMVR solution
News
2 April, 2025
TISSIUM Announces Clinical Results of COAPTIUM® CONNECT System for Atraumatic Sutureless Nerve Repair
News
2 April, 2025
CorWave announces the appointment of Dawn Sadlowski-Buisserez as Vice President of Operations to support the ramp-up of production
News
1 April, 2025
Nuage Therapeutics appoints Dr. Stuart Hughes as CEO and Vanessa Malier as Chair
News
20 March, 2025
Nitrase Therapeutics unveils protein with newly characterized enzymatic function involved in the pathogenesis of Parkinson’s Disease
News
20 March, 2025
Sitryx initiates Phase 1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219
News
18 March, 2025
Moon Surgical receives FDA clearance for ScoPilot™ on Maestro, industry's first AI-enhanced intraoperative capability, powered by NVIDIA Holoscan

Rasmus Holm-Jorgensen appointed CFO at AAVantgarde

Mainstay Medical announces exclusive coverage of ReActiv8® by Anthem Blue Cross/Blue Shield

Purespring Therapeutics granted European Medicines Agency (EMA) orphan drug designation for PS-002 for the treatment of patients with primary IgA nephropathy (IgAN)

CorWave announces successful completion of 6-month chronic in vivo study, paving the way for clinical trial initiation

2024 Impact Report: Delivering Impact

iOmx Therapeutics Receives Regulatory Approval of Clinical Trial Application for IOMX-0675

ProQR strengthens leadership with appointments of CFO and CMO to support next phase of growth

Myricx Bio Announces Expansion of its Leadership Team to Advance NMTi-ADCs into Clinical Development

Invivo Partners joins Sofinnova in Signadori Bio

HighLife granted US FDA Breakthrough Device Designation for its TMVR solution

TISSIUM Announces Clinical Results of COAPTIUM® CONNECT System for Atraumatic Sutureless Nerve Repair

CorWave announces the appointment of Dawn Sadlowski-Buisserez as Vice President of Operations to support the ramp-up of production

Nuage Therapeutics appoints Dr. Stuart Hughes as CEO and Vanessa Malier as Chair

Nitrase Therapeutics unveils protein with newly characterized enzymatic function involved in the pathogenesis of Parkinson’s Disease

Sitryx initiates Phase 1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219

Moon Surgical receives FDA clearance for ScoPilot™ on Maestro, industry's first AI-enhanced intraoperative capability, powered by NVIDIA Holoscan